ARBUTUS BIOPHARMA INC has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), Taiwan and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are METACRINE INC, ENTERPRISE THERAPEUTICS LTD and SHANDONG DANHONG PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Taiwan | 5 | |
#3 | Australia | 2 | |
#4 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Chen Shuai | 9 |
#2 | Dorsey Bruce D | 7 |
#3 | Fan Yi | 7 |
#4 | Gotchev Dimitar B | 6 |
#5 | Quintero Jorge | 5 |
#6 | Kakarla Ramesh | 5 |
#7 | Cole Andrew G | 5 |
#8 | Nguyen Duyan | 4 |
#9 | Bi Yingzhi | 4 |
#10 | Sofia Michael J | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021025976A1 | Substituted cyclopropyl-2,2'-bipyrimidinyl compounds, analogues thereof, and methods using same | |
TW202033523A | Substituted polycyclic carboxylic acids, analogues thereof, and methods using same | |
TW202003487A | Substituted 2,2’-bipyrimidinyl compounds, analogues thereof, and methods using same | |
WO2019177937A1 | Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same |